Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: Lung Neoplasms and NF1[original query] |
---|
Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors. Cancer genetics 2016 Jan . Mukherjee S, Ma Z, Wheeler S, Sathanoori M, Coldren C, Prescott J L, Kozyr N, Bouzyk M, Correll M, Ho H, Chandra P K, Lennon P |
Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Feb . Redig Amanda J, Capelletti Marzia, Dahlberg Suzanne E, Sholl Lynette M, Mach Stacy L, Fontes Caitlin, Shi Yunling, Chalasani Poornima, Janne Pasi |
HER2 mutations in Chinese patients with non-small cell lung cancer. Oncotarget 2016 Aug . Song Zhengbo, Yu Xinmin, Shi Zhiyong, Zhao Jun, Zhang Yipi |
RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Nov . Hayashi Takuo, Desmeules Patrice, Smith Roger S, Drilon Alexander, Somwar Romel, Ladanyi Ma |
Racial Disparities in the Molecular Landscape of Cancer. Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
RASA1/NF1-Mutant Lung Cancer: Racing to the Clinic? Clinical cancer research : an official journal of the American Association for Cancer Research 2018 1 24 (6): 1243-1245. Kitajima Shunsuke, Barbie David |
Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics 2019 9 9 (19): 5532-5541. Tong Lin, Ding Ning, Tong Xiaoling, Li Jiamin, Zhang Yong, Wang Xiaodan, Xu Xiaobo, Ye Maosong, Li Chun, Wu Xue, Bao Hairong, Zhang Xin, Hong Qunying, Song Yuanlin, Shao Yang W, Bai Chunxue, Zhou Jian, Hu J |
Co-occurring genetic alterations predict distant metastasis and poor efficacy of first-line EGFR-TKIs in EGFR-mutant NSCLC. Journal of cancer research and clinical oncology 2019 Aug . Deng Li-Li, Gao Ge, Deng Hong-Bin, Wang Feng, Wang Zhi-Hui, Yang |
NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas. Cancer medicine 2019 Jun . Tlemsani Camille, Pécuchet Nicolas, Gruber Aurelia, Laurendeau Ingrid, Danel Claire, Riquet Marc, Le Pimpec-Barthes Françoise, Fabre Elizabeth, Mansuet-Lupo Audrey, Damotte Diane, Alifano Marco, Luscan Armelle, Rousseau Benoit, Vidaud Dominique, Varin Jennifer, Parfait Beatrice, Bieche Ivan, Leroy Karen, Laurent-Puig Pierre, Terris Benoit, Blons Helene, Vidaud Michel, Pasmant Er |
Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer. Disease markers 2019 2019 3837687. Kang Jingjing, Luo Yang, Wang Di, Men Yu, Wang Jianyang, Che Yi-Qun, Hui Zhougua |
Precision oncology of lung cancer: genetic and genomic differences in Chinese population. NPJ precision oncology 2019 3 14. Shen Hongbing, Zhu Meng, Wang Che |
Mutation Profile of Resected EGFR-Mutated Lung Adenocarcinoma by Next-Generation Sequencing. The oncologist 2019 3 24 (10): 1368-1374. Zhao Ze-Rui, Lin Yao-Bin, Ng Calvin S H, Zhang Rong, Wu Xue, Ou Qiuxiang, Chen Wendan, Zhou Wen-Jie, Lin Yong-Bin, Su Xiao-Dong, Shao Yang W, Long H |
Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian). Journal of thoracic disease 2020 Jul 12 (7): 3776-3784. Izumi Motohiro, Suzumura Tomohiro, Ogawa Koichi, Matsumoto Yoshiya, Sawa Kenji, Yoshimoto Naoki, Tani Yoko, Watanabe Tetsuya, Kaneda Hiroyasu, Mitsuoka Shigeki, Asai Kazuhisa, Kawaguchi Tomo |
Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations. Cancer biomarkers : section A of Disease markers 2020 Feb . Geng Hua, Li Shixiong, Guo Yixian, Yan Fang, Han Yuebin, Xu Meilin, Cui Yanz |
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
Molecular Analysis of Oncogenic Mutations in Resected Margins by Next-Generation Sequencing Predicts Relapse in Non-Small Cell Lung Cancer Patients. OncoTargets and therapy 2020 13 9525-9531. Wei Weitian, Li Xingliang, Song Mengmeng, Wang Changch |
Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey. BMC cancer 2020 Oct 20 (1): 994. Sun Peng, Li Yue, Chao Xue, Li Jibin, Luo Rongzhen, Li Mei, He Jieh |
Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer. Balkan medical journal 2021 Nov 38 (6): 382-391. Kahraman Çetin Nesibe, Erdo?du ?brahim Halil, Bozkurt Emin, Meteo?lu ?brah |
NF1-Mutant Cancer and Immune Checkpoint Inhibitors: A Large Database Analysis. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e421. Li X, Yu J, Wang |
Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2022 7 171 18-25. Liu Chang, Liu Cuicui, Liao Jiatao, Yin Jiani C, Wu Xianghua, Zhao Xinmin, Sun Si, Wang Huijie, Hu Zhihuang, Zhang Yao, Yu Hui, Shao Yang, Wang Jial |
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients. Cancer medicine 2022 Jun . Tian Hong-Xia, Chen Zhi-Hong, Jie Guang-Ling, Wang Zhen, Yan Hong-Hong, Wu Si-Pei, Zhang Shui-Lian, Lu Dan-Xia, Zhang Xu-Chao, Wu Yi-Lo |
Mutational status of main driver genes influences the prognosis of stage I-III lung adenocarcinoma patients underwent radical surgery. Translational cancer research 2021 Jul 10 (7): 3286-3298. Liao Hongliang, Luo Xiaoyan, Liang Yaqin, Wan Renping, Xu Me |
Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 2023 4 7 e2200421. Wisinski Kari B, Flamand Yael, Wilson Melissa A, Luke Jason J, Tawbi Hussein A, Hong Fangxin, Mitchell Edith P, Zwiebel James A, Chen Helen, Gray Robert J, Li Shuli, McShane Lisa M, Rubinstein Lawrence V, Patton David, Williams P Mickey, Hamilton Stanley R, Behrens Robert J, Pennington Kathryn P, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
Uses of Vascular Endothelial Growth Factor C as a Lung Adenocarcinoma Prognostic Biomarker. World journal of oncology 2023 3 14 (1): 51-59. Chen Shi, Pan Ting Yu, Wu Xiao, Li Tian, Wei Yu, He Hai Lang, Zhou Xian Mei, Wang Qian, Zhu Ji Pi |
Druggable genomic landscapes of high-grade gliomas. Frontiers in medicine 2023 12 10 1254955. Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, , Jenna Canzoniero, Stuart A Grossman, Kristen Marrone, Karisa C Schreck, Valsamo Anagnost |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: